Oracle Platform to Deliver Drug Trial Data to Trump

March 25, 2020   |   by James G. Dalton

An online platform by Oracle is going to collect data and deliver it to coronavirus task force health experts to determine the efficacy of experimental drug treatments promoted by President Donald Trump, according to sources.

Malaria drugs chloroquine and hydroxychloroquine have not been approved by the Food and Drug Administration to tread COVID-19, but their use in trials will be recorded and shared with the White House before potential approval, five senior Trump administration officials told The New York Times.

Trump has faced criticism and even some caution by National Institute of Health’s Dr. Anthony Fauci by calling the treatments a potential “game-changer,” but the president has moved the U.S. to acquire and administer front-line testing of late.

The online portal will give officials immediate ability to track the symptoms and trials in order to streamline potential governmental actions amid the global coronavirus pandemic.

Oracle co-founder Lawrence J. Ellison is a Trump supporter and the project has been endorsed by Dr. David B. Agus of University of Southern California, senior officials told the Times.

The cooperative effort is designed to deliver real-time science and data so the administration can deliver expedited guidance and potential U.S. healthcare system policy.

Reports of the drug’s use by China and France have been promising, per the report.

“I think there’s a major misconception in this country that getting good evidence means red tape,” Johns Hopkins Bloomberg School of Public Health’s Dr. Joshua M. Sharfstein told the Times. “Getting good evidence is knowing the difference between something that works and something that doesn’t.”

An Arizona man died and his wife was critical after ingesting chloroquine phosphate, a substance used to clean fish tanks, according to Banner Health.

“Trump kept saying it was basically pretty much a cure,” the woman who self-administered it, told the Times.

But Banner Poison and Drug Information Center Dr. Daniel Brooks told the Times, “It’s incredibly dangerous and foolish for people to be doing this.”

“This is not going to be a magic pill for us to get us through this,” he added.

via newsmax

Recent Comments

  1. Sima M Schwartz

    Reply
    March 25, 2020 @ 3:21 pm

    Thanks for asking my comment on the issue of potential knowledge from a trial of some ingredients that already being known by some positive results of cure COVID-19 in China and France! I have knowledge that Israel participates in cure it. But the question is exactly about several ingredients. And the names of participating institutions and doctors making me think that President’s decision to help USA to shorten the period of treatment and possibility to spread this virus, is Correct Ones again! If trials start upon a request of the patients or their relatives, during the trial could be new approach of a treatment, and participating perconal and the equipment at that time will be already in service, rather than starting! Sincerely, Sima M Schwartz.

Leave Your Comment

%d bloggers like this: